From DNA to Doses: How Pharmacogenomics Transforms Depression Care in Community Pharmacy
Pharmacogenomic testing can identify these genetic variations, allowing healthcare providers to adjust drug selection and dosage accordingly. These tests typically involve a simple cheek swab or saliva sample, which is then analysed to identify specific genetic variations that affect drug metabolism and response. Cytochrome P450 (CYP450) enzyme is responsible for the metabolism of many antidepressants. CYP2D6 and CYP2C19 may cause variations in how drugs are metabolized. A neurotransmitter invol
Authors
- Narjis Fatima (ORCID: https://orcid.org/0000-0002-7475-9250)
- Momin Shabana
- T. Kusuma Teja
- Umar Zeshan
Publication Details
- Journal
- Archives of Pharmacy Practice
- Published
- 2025-01-01
- DOI
- https://doi.org/10.51847/si19cmljuz
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00